Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na v 1.7 for the Treatment of Pain.

MLA

Adams, Gregory L., et al. “Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na v 1.7 for the Treatment of Pain.” Journal of Medicinal Chemistry, vol. 65, no. 1, Jan. 2022, pp. 485–96. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.1c01570.

APA

Adams, G. L., Pall, P. S., Grauer, S. M., Zhou, X., Ballard, J. E., Vavrek, M., Kraus, R. L., Morissette, P., Li, N., Colarusso, S., Bianchi, E., Palani, A., Klein, R., John, C. T., Wang, D., Tudor, M., Nolting, A. F., Biba, M., Nowak, T., … Tellers, D. M. (2022). Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na v 1.7 for the Treatment of Pain. Journal of Medicinal Chemistry, 65(1), 485–496. https://doi.org/10.1021/acs.jmedchem.1c01570

Chicago

Adams, Gregory L, Parul S Pall, Steven M Grauer, Xiaoping Zhou, Jeanine E Ballard, Marissa Vavrek, Richard L Kraus, et al. 2022. “Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na v 1.7 for the Treatment of Pain.” Journal of Medicinal Chemistry 65 (1): 485–96. doi:10.1021/acs.jmedchem.1c01570.